Definition requires five years off myeloma treatment with sustained MRD negativity, assessed with technology sensitive enough to identify one myeloma cell among one million cells

SEATTLE, Sept. 25, 2026 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today highlighted the new consensus definition of cure for multiple myeloma, presented at the International Myeloma Society (IMS) 23rd Annual Meeting in Glasgow, Scotland, on behalf of IMS and the International Myeloma Working Group (IMWG).

Long considered an incurable disease, multiple myeloma is entering a new phase in which some patients are remaining free of detectable disease for years after treatment ends. Significant advances in both myeloma therapeutic strategies and disease monitoring technologies are giving clinicians more effective ways to drive deep responses and more sensitive ways to measure them. As more patients achieve these outcomes, a clear standard for determining when a long-term response may be considered a cure is necessary. The new consensus definition establishes that standard and places sustained measurable residual disease (MRD) negativity at the center of determining whether a deep response has endured over time.

Under the consensus definition reached by global myeloma experts, a patient with newly diagnosed or relapsed disease may be considered cured after five years in complete remission without any myeloma treatment. During that period, the definition requires:

  • At least four negative MRD assessments, including one at the five-year mark, with no positive result in between.
  • MRD tests must use next-generation sequencing or next-generation flow at a sensitivity of 10⁻⁶, or one myeloma cell among one million cells.
  • Advanced imaging, using PET/CT or diffusion-weighted whole-body MRI, must show no disease at the start and end of the period, with no positive scan in between if additional scans are performed.

These criteria illustrate that advanced disease assessment methodologies, including clonoSEQ®, will play a central role in determining which patients meet the definition of cure.

“In the world of treating multiple myeloma, we have now reached a point where we can actually cure patients. Part of that cure definition is that the patient has no measurable disease in their bone marrow,” said Dr. Jeffrey Wolf, clinical professor, Department of Medicine, University of California, San Francisco.  “The ideal way of measuring that is to use the clonoSEQ Assay, which has been proven over many years to be the most reproducible way of defining residual disease in these patients.”

Establishing this consensus definition is the beginning of a new era for patients; significant ongoing research will be required to continue to expand the fraction who are cured and to better understand the probability of cure in specific patient subpopulations. 

“Patients are excited to hear the cure conversation gain momentum but want to balance the hope with their lived reality,” said Jenny Ahlstrom, myeloma patient and CEO and founder, HealthTree Foundation. “Given that all myeloma is not the same, learning who can and will be cured will be one of the most important discoveries in the near future.”

“The consensus definition of cure in myeloma marks a defining moment for the patient community and a landmark achievement for the field. Together with last week’s NCCN Guidelines® update, this development clearly affirms that highly sensitive MRD assessment should be systematically integrated into routine myeloma care,” said Susan Bobulsky, chief commercial officer, MRD, Adaptive Biotechnologies. “As the first and only FDA-cleared next-generation sequencing MRD test, clonoSEQ is uniquely positioned to support the level of rigor the cure definition requires, giving clinicians a precise way to measure deep responses over time and offering patients clearer insight into the outcome of their treatment.”

About clonoSEQ
clonoSEQ® is the first and only FDA-cleared in vitro diagnostic (IVD) test for detecting and tracking minimal (or measurable) residual disease (MRD) in patients with multiple myeloma (MM) or B-cell acute lymphoblastic leukemia (B-ALL) using bone marrow, and in patients with chronic lymphocytic leukemia (CLL) using blood or bone marrow. clonoSEQ is also available in diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and other lymphoid cancers and specimen types as a CLIA-validated laboratory-developed test (LDT). clonoSEQ is covered by Medicare for MM, CLL, ALL, DLBCL and MCL.

clonoSEQ identifies and quantifies DNA sequences in malignant cells—detecting one cancer cell in one million healthy cells—to help clinicians and researchers assess and monitor MRD with precision over time. It delivers standardized, sensitive results that inform treatment decisions, predict outcomes, and detect relapses earlier. clonoSEQ has been extensively studied in more than 300 peer-reviewed publications.

clonoSEQ is CE-marked under the EU In Vitro Diagnostic Regulation (IVDR). For intended use details in the EU, see the instructions for use, available on request.

To review the FDA-cleared uses of clonoSEQ, visit clonoSEQ.com/technical-summary.

About Adaptive Biotechnologies
Adaptive Biotechnologies (“we” or “our”) is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. We believe the adaptive immune system is nature’s most finely tuned diagnostic and therapeutic for most diseases, but the inability to decode it has prevented the medical community from fully leveraging its capabilities. Our proprietary immune medicine platform reveals and translates the massive genetics of the adaptive immune system with scale, precision, and speed. We apply our platform to partner with biopharmaceutical companies, inform drug development, and develop clinical diagnostics across our two business areas: Minimal Residual Disease (MRD) and Immune Medicine. Our commercial products and clinical pipeline enable the diagnosis, monitoring, and treatment of diseases such as cancer, autoimmune disorders, and infectious diseases. Our goal is to develop and commercialize immune-driven clinical products tailored to each individual patient.

Forward-Looking Statements
This press release contains forward-looking statements that are based on management’s beliefs and assumptions and on information currently available to management. All statements contained in this release other than statements of historical fact are forward-looking statements, including statements regarding our ability to develop, commercialize and achieve market acceptance of our current and planned products and services, our research and development efforts, and other matters regarding our business strategies, use of capital, results of operations and financial position, and plans and objectives for future operations.

In some cases, you can identify forward-looking statements by the words “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. These statements involve risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. These risks, uncertainties and other factors are described under “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in the documents we file with the Securities and Exchange Commission from time to time. We caution you that forward-looking statements are based on a combination of facts and factors currently known by us and our projections regarding the future, about which we cannot be certain. As a result, the forward-looking statements may not prove to be accurate. The forward-looking statements in this press release represent our views as of the date hereof. We undertake no obligation to update any forward-looking statements for any reason, except as required by law.

ADAPTIVE INVESTORS
Karina Calzadilla, Vice President, Investor Relations and FP&A
201-396-1687
investors@adaptivebiotech.com

ADAPTIVE MEDIA
Erica Jones, Associate Corporate Communications Director
206-279-2423
media@adaptivebiotech.com

HERNDON, Va., Sept. 25, 2026 (GLOBE NEWSWIRE) — Navient (Nasdaq: NAVI) has appointed Diane Offereins, a well-respected executive with over 35 years of experience in financial services, to the Navient board of directors, effective September 24, 2026.

“We are excited to have Diane join the Navient board and believe she is an excellent addition with her many years of experience in the financial services industry and expertise in executive compensation, information technology and cybersecurity,” said Edward Bramson, CEO and chair of the Navient board of directors.

Offereins is currently serving on the boards of Lendbuzz, Flywire and Brighthouse Financial following over 24 years with Discover Financial Services where she served as Global Chief Information Officer and completing her career as Executive Vice President, Payment Services. She graduated with a BBA in accounting from Loyola University in New Orleans.

This appointment comes after the retirement of a board member in June 2026.

About Navient
Navient (Nasdaq: NAVI) creates long-term value for customers and investors with responsible lending, flexible refinancing, trusted servicing oversight, and decades of education finance and portfolio management expertise. Through our Earnest business, we help customers confidently achieve financial success through digital financial services. Our employees thrive in a culture of belonging, where they are supported and proud to deliver meaningful outcomes. Learn more on Navient.com.

Contact:  
Media: Cate Fitzgerald, 703-831-6347, catherine.fitzgerald@navient.com
Investors: Micah Andrews, 571-415-5413, micah.andrews@navient.com
  Roger Yankoupe, 571-592-8569, roger.yankoupe@navient.com

ORLANDO, Fla., Sept. 25, 2026 (GLOBE NEWSWIRE) — Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) today announced the appointment of Robert J. O’Neill to its Advisory Board. O’Neill is a highly decorated former U.S. Navy SEAL, New York Times best-selling author, and nationally recognized speaker on leadership and resilience.

O’Neill served 16 years in the U.S. Navy, including eight years with the Naval Special Warfare Development Group (SEAL Team Six), and took part in more than 400 combat missions across four theaters of war. He is widely known for his role in Operation Neptune’s Spear, the 2011 mission that resulted in the death of Osama bin Laden. Over his career he was decorated more than 50 times, including two Silver Stars and four Bronze Stars with Valor. He is the author of the New York Times best-selling memoir The Operator: Firing the Shots That Killed Osama bin Laden and My Years as a SEAL Team Warrior, and is a regular contributor to national media on leadership, decision-making under pressure, and national security.

O’Neill remains closely connected to the military and veteran community, and has been a visible advocate for expanding access to emerging health treatments, including appearing alongside fellow veterans at this year’s White House executive order signing aimed at accelerating research and access to psychedelic-assisted therapies through the VA. His continued engagement with veteran service organizations and the broader military community reflects a career-long commitment to those he served alongside. His experience in fighting for adequate care pairs perfectly with Nutriband’s advancement of AVERSA as the company continues towards approval and commercialization of AVERSA Fentanyl which would be the worlds first and only abuse deterrent fentanyl patch if approved.

“Rob has spent his career operating at the highest levels of pressure, precision, and decision-making, and he’s continued that same commitment through his advocacy for adequate care and the military community he comes from,” said Gareth Sheridan, CEO of Nutriband Inc. “Those are exactly the qualities we look for as we scale Nutriband and AVERSA™ into new markets, and his perspective will be a real asset to our team as we continue to grow.”

Nutriband’s Advisory Board supports the Company’s executive team on strategy, growth, and execution as it advances its pipeline of abuse-deterrent transdermal products, including AVERSA™ Fentanyl.

About Nutriband Inc.

We are primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Our lead product under development is an abuse deterrent fentanyl patch incorporating our AVERSA™ abuse deterrence technology. AVERSA™ technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.

The Company’s website is www.nutriband.com. Any material contained in or derived from the Company’s websites or any other website is not part of this press release.

Forward-Looking Statements

Certain statements contained in this press release, including, without limitation, statements containing the words “believes,” “anticipates,” “expects” and words of similar import, constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve both known and unknown risks and uncertainties. The Company’s actual results may differ materially from those anticipated in its forward-looking statements as a result of a number of factors, including those including the Company’s ability to develop its proposed abuse-deterrent fentanyl transdermal system and other proposed products, its ability to obtain patent protection for its abuse technology, its ability to obtain the necessary financing to develop products and conduct the necessary clinical testing, its ability to obtain Federal Food and Drug Administration approval to market any product it may develop in the United States and to obtain any other regulatory approval necessary to market any product in other countries, including countries in Europe, its ability to market any product it may develop, its ability to create, sustain, manage or forecast its growth; its ability to attract and retain key personnel; changes in the Company’s business strategy or development plans; competition; business disruptions; adverse publicity and international, national and local general economic and market conditions and risks generally associated with an undercapitalized developing company, as well as the risks contained under “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the Company’s periodic and current reports on Form 10-K, Forms 10-Q and 8-K and the Company’s other filings with the Securities and Exchange Commission. Except as required by applicable law, we undertake no obligation to revise or update any forward-looking statements to reflect any event or circumstance that may arise after the date hereof.

Contact Information:
Nutriband Inc.
Phone: 407-377-6695
Email: info@nutriband.com

Bullard Ave & McDowell Rd Location to Celebrate Grand Opening on September 27th

Black Rock Coffee Bar

Opening September 27 in Goodyear
Opening September 27 in Goodyear

Black Rock Coffee Bar

New Goodyear Location - Opening September 27
New Goodyear Location – Opening September 27

Scottsdale, AZ, Sept. 25, 2026 (GLOBE NEWSWIRE) — Black Rock Coffee Bar, the Oregon-born boutique coffee company known for its specialty coffees, teas, smoothies, and popular Fuel® energy drinks, is expanding its footprint in the Valley with a new location opening this week. 

The store, located at 14880 W McDowell Rd will officially celebrate its grand opening in Goodyear on Sunday, September 27th. Guests can enjoy $3 medium drinks all day, with the celebration continuing into the following day with a signature grand opening sticker giveaway. With this opening, Black Rock’s Arizona presence grows to 63 locations, underscoring the brand’s steady expansion throughout the Valley.  

“As we continue to grow throughout the Valley, we’re excited to open another location in Goodyear,” said Mark Davis, CEO of Black Rock Coffee Bar. “We’re looking forward to introducing more guests to the Black Rock experience and creating a welcoming place to fuel their day.” 

Guests can also take advantage of the Black Rock Rewards app, where every purchase—whether in-store, online, or through the app—earns “bolts” that can be redeemed for free beverages. Recent menu additions, like Black Rock’s protein-packed Egg Bites, are also included in the program. 

Black Rock Coffee Bar is beloved for its handcrafted beverages, including the Caramel Blondie, a sweet and creamy signature blend; the Mexican Mocha, a spicy twist with hints of vanilla, almond, and cinnamon; and the Jackhammer, a vanilla mocha with an extra double shot; as well as its in-house developed Fuel energy drink, customizable with over 20 fruit flavors.  These can be enjoyed alongside sweet and savory food items, including the recently launched Grilled Cheese and Pumpkin Blondie Cake Pop. For an extra kick of protein, guests can add Black Rock’s new Protein Cold Foam, Protein Boosted Milk or Protein Boost to their drinks. 

In addition to Black Rock menu staples, guests can enjoy limited-time offerings like the Pumpkin Spiced Latte, Pumpkin Blondie, and Pumpkin Spice Cookie Latte with Cookie Butter Cold Foam. The brand’s Fall Remix seasonal drinks are also now available, featuring the Caramel Apple Butter Shaken Espresso, Cinnamon Bun Latte, and Spellbound Berry Fuel, offering a mix of nostalgic and refreshing flavors.  

For more information, visit https://br.coffee/ and follow @blackrockcoffeebar on Facebook and Instagram, and @blackrockcoffeeofficial on TikTok for updates on new locations, promotions, and seasonal offerings. 

 

About Black Rock Coffee Bar  

Black Rock Coffee Bar is a national boutique coffee shop that is known for its premium roasted coffees, teas, smoothies and flavorful Fuel® energy drinks. Founded as a family owned and operated business in Oregon in 2008, Black Rock Coffee Bar has grown to over 200 retail locations in seven states. The Black Rock culture prides itself on not only being a positive force for the communities it serves, but also the team members that fuel their locations day in and day out. An important aspect of their team mission is to recognize those that go above and beyond by displaying the 4G’s of Black Rock – grit, growth, gratitude, and grace. For more information, visit https://br.coffee/.  

Attachments

CONTACT: Audrey Arbogast
Black Rock Coffee Bar
audrey.arbogast@havasred.com

New York, NY, Sept. 25, 2026 (GLOBE NEWSWIRE) — Alpha Compute Corp. (Nasdaq: ALP) (“Alpha Compute” or the “Company”), a provider of high-density AI compute infrastructure and enterprise GPU services, today announced that it has regained compliance with the Nasdaq Stock Market’s minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2).

On March 2, 2026, Nasdaq’s Listing Qualifications Staff (the “Staff”) notified the Company that its Ordinary Shares had failed to maintain a minimum closing bid price of $1.00 per share over the previous 30 consecutive business days, as required by Nasdaq Listing Rule 5550(a)(2).

The Company is pleased to announce that the Staff has determined that, for the 11 consecutive business days from September 9, 2026 through September 23, 2026, the closing bid price of the Company’s Ordinary Shares was at or above $1.00 per share.

Accordingly, Alpha Compute has regained compliance with Nasdaq Listing Rule 5550(a)(2), and the matter is now closed.

“We are pleased to have regained compliance with Nasdaq’s minimum bid price requirement,” said Wes Levitt, Chief Financial Officer of Alpha Compute. “This milestone reflects our continued focus on strengthening the Company and delivering long-term value for our shareholders.”

About Alpha Compute Corp.

Alpha Compute Corp. (Nasdaq: ALP) is a vertically integrated AI infrastructure company specializing in GPU-as-a-service and AI Confidential Compute. Alpha Compute’s mission is to support clients, subsidiaries, and partners across critical sectors including: finance, defense, intelligence, and media with the essential framework for any organization requiring secure, confidential computing environments. For more information, please visit: https://www.alphacompute.ai/

Alpha Compute Corp. is domiciled in the British Virgin Islands and Delaware with offices in New York, Los Angeles, Miami, Amsterdam and Toronto, and is a founding partner of the Right2Compute Coalition (www.right2compute.com).

Forward-Looking Statements 
This press release contains forward-looking statements within the meaning of applicable securities laws. All statements other than statements of historical fact, including those preceded by, followed by, or incorporating words such as “believes,” “expects,” “anticipates,” “intends,” “estimates,” “plans,” “may,” “will,” “potential,” “continues,” or similar expressions are forward-looking statements. 

Forward-looking statements in this release include, without limitation: successful completion of the Tioga East acquisition and the development and financing of the planned data center, the; title, acreage and net revenue interest; financing and partner arrangements; gas availability, projected power costs, well and generation plans; development, permitting, construction and commercial operation of the planned initial 200 MW; potential expansion to 1 GW; and potential economic, environmental and community impacts. 

These statements involve known and unknown risks and uncertainties that may cause actual results to differ materially from those expressed or implied, including: the timing and progress of the Company’s strategic initiatives; reliance on third-party vendors and partners; the ability to secure additional financing; uncertainty around the Company’s investments and legacy business; risks related to technology platforms and ecosystems; and general market and economic conditions. A more complete discussion of these risks is set forth under “Item 3 – Key Information – Risk Factors” in the Company’s Annual Report on Form 20-F for the year ended March 31, 2026. 

Undue reliance should not be placed on these forward-looking statements. The forward-looking statements contained herein are made as of the date of this press release, and the Company undertakes no obligation to update or revise them publicly, except as required by law. 

Investor & Media Contact 

Alpha Compute Corp.
ir@alphacompute.ai
www.alphacompute.ai

CONTACT: ir(at)alphacompute.ai

New Location Marks 7th Store in California

Black Rock Coffee Bar

Opening September 30 in Leander
Opening September 30 in Leander

Black Rock Coffee Bar

New Leander Location Coming on September 30th
New Leander Location Coming on September 30th

Scottsdale, AZ, Sept. 25, 2026 (GLOBE NEWSWIRE) — Black Rock Coffee Bar, the Oregon-born boutique coffee chain celebrated for its specialty coffees, teas, smoothies, and signature Fuel® energy drinks, is growing its footprint in California with the opening of a new store in Montclair. 

The store, located at 8970 Central Ave, will officially open its doors on Wednesday, September 30th. This opening marks Black Rock’s seventh California location and reinforces the brand’s steady expansion across the state. Guests can enjoy the following specials during opening week: 

  • Wednesday, 9/30: Free 16oz Drinks 
  • Thursday, 10/1: Buy One, Get One Free Drinks 
  • Friday, 10/2: 50% Off a Drink w/ Food Purchase 
  • Saturday, 10/3: Signature Grand Opening Sticker with purchase while supplies last 
  • Sunday, 10/4: Free T-Shirt with purchase while supplies last 
  • Monday, 10/5: $2 Off Any Size Drink 

“California has been an important part of Black Rock’s growth, and we’re excited to expand into Montclair,” said Mark Davis, CEO of Black Rock Coffee Bar. “We look forward to becoming part of the community and creating a welcoming place for guests to enjoy their favorite drinks and fuel their day!” 

Guests can also take advantage of the Black Rock Rewards app, where every purchase—whether in-store, online, or through the app—earns “bolts” that can be redeemed for free beverages. Recent menu additions, like Black Rock’s protein-packed Egg Bites, are also included in the program. 

Black Rock Coffee Bar is beloved for its handcrafted beverages, including the Caramel Blondie, a sweet and creamy signature blend; the Mexican Mocha, a spicy twist with hints of vanilla, almond, and cinnamon; and the Jackhammer, a vanilla mocha with an extra double shot; as well as its in-house developed Fuel energy drink, customizable with over 20 fruit flavors.  These can be enjoyed alongside sweet and savory food items, including the recently launched Grilled Cheese and Pumpkin Blondie Cake Pop. For an extra kick of protein, guests can add Black Rock’s new Protein Cold Foam, Protein Boosted Milk or Protein Boost to their drinks. 

In addition to Black Rock menu staples, guests can enjoy limited-time offerings like the Pumpkin Spiced Latte, Pumpkin Blondie, and Pumpkin Spice Cookie Latte with Cookie Butter Cold Foam. The brand’s Fall Remix seasonal drinks are also now available, featuring the Caramel Apple Butter Shaken Espresso, Cinnamon Bun Latte, and Spellbound Berry Fuel, offering a mix of nostalgic and refreshing flavors.  

For more information, visit https://br.coffee/ and follow @blackrockcoffeebar on Facebook and Instagram, and @blackrockcoffeeofficial on TikTok for updates on new locations, promotions, and seasonal offerings. 

 

About Black Rock Coffee Bar  

Black Rock Coffee Bar is a national boutique coffee shop that is known for its premium roasted coffees, teas, smoothies and flavorful Fuel® energy drinks. Founded as a family owned and operated business in Oregon in 2008, Black Rock Coffee Bar has grown to over 200 retail locations in seven states. The Black Rock culture prides itself on not only being a positive force for the communities it serves, but also the team members that fuel their locations day in and day out. An important aspect of their team mission is to recognize those that go above and beyond by displaying the 4G’s of Black Rock – grit, growth, gratitude, and grace. For more information, visit https://br.coffee/. 

 

Attachments

CONTACT: Audrey Arbogast
Black Rock Coffee Bar
audrey.arbogast@havasred.com

NANO Nuclear Energy Inc.

NANO Nuclear, IP3 and Cybernetic Intelligence Sign Letter of Intent to Pursue Nuclear Powered AI Infrastructure Projects
NANO Nuclear, IP3 and Cybernetic Intelligence Sign Letter of Intent to Pursue Nuclear Powered AI Infrastructure Projects

Letter of Intent Names NANO Nuclear as a Preferred Nuclear Technology & Services Provider for Potential Future Projects

New York, N.Y., Sept. 25, 2026 (GLOBE NEWSWIRE) — NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or the “Company”), IP3 Corporation (“IP3”) and Cybernetic Intelligence announced the signing a Letter of Intent (LOI) setting out a framework to jointly pursue nuclear-powered artificial intelligence (AI), national security and computing and other infrastructure opportunities in the United States and select international markets.

The LOI names NANO Nuclear as a preferred provider of nuclear technology and services to IP3 and Cybernetic Intelligence for opportunities pursued through the collaboration. The relationship is expected to leverage NANO Nuclear’s capabilities across advanced microreactor technology, nuclear fuel supply and logistics, and reactor operations.

Figure 1 – NANO Nuclear, IP3 and Cybernetic Intelligence Sign Letter of Intent to Pursue Nuclear Powered AI Infrastructure Projects

Enabling Potential New Commercial Pathways for Advanced Nuclear

NANO Nuclear believes growing demand for secure, reliable and resilient power across AI, national security and computing and other critical infrastructure will create new applications for advanced nuclear technology beyond traditional utility-scale generation.

The collaboration brings together complementary capabilities intended to help convert those opportunities into potential commercial projects: NANO Nuclear as a provider of advanced nuclear technology, fuel and related services; IP3 providing project origination, development, financing and government engagement capabilities; and Cybernetic Intelligence contributing expertise in AI infrastructure, compute sovereignty and access to potential defense, intelligence and commercial compute customers.

Together, the parties intend to pursue an integrated development approach that connects advanced nuclear technology with identifiable energy demand, secure computing requirements, project development and potential access to capital. This is expected to include identifying potential end-users and host sites, assessing applicable regulatory and policy frameworks, developing project and feasibility materials, engaging potential financing and project partners, and evaluating the supply-chain and manufacturing capabilities required to support deployment.

The parties also expect to evaluate potential financing pathways for mutually agreed projects, including infrastructure and project finance, government-supported programs and other sources of institutional capital. These activities are intended to create a potential pathway from opportunity origination and project structuring through financing and commercial deployment.

Pursuing a Pipeline of Strategic Commercial Opportunities

The parties intend to jointly evaluate and pursue multiple potential commercial opportunities across the United States and select international markets. Areas under consideration include potential advanced reactor pilot programs for military applications, energy-resilience solutions for defense and intelligence installations, sovereign AI and high-performance computing infrastructure, maritime nuclear applications, and strategic international energy and infrastructure projects.

As an initial workstream under the LOI, the parties intend to identify and commence a mutually agreed pilot program, selected based on factors including project readiness, strategic priority and available resources. The pilot is expected to provide a framework for applying the parties’ combined nuclear, infrastructure development and secure computing capabilities to a defined deployment opportunity. Any pilot would be subject to a separate project-specific agreement establishing its scope, timeline, commercial terms and deliverables.

In parallel, the parties expect to evaluate potential host sites and end-users, engage relevant government agencies, regulators, financiers and infrastructure partners, and assess supply-chain, manufacturing, localization and workforce requirements for potential deployments.

“Advanced nuclear is moving beyond traditional power markets as AI, national security and other strategic industries seek secure, reliable and resilient sources of energy. This collaboration is designed to position NANO Nuclear’s technology at the center of that emerging opportunity,” said James Walker, Chief Executive Officer of NANO Nuclear Energy. “Being selected as a preferred nuclear technology and services provider for opportunities explored under this collaboration is another meaningful step in expanding future commercial pathways for our company. By combining our reactor and fuel capabilities with IP3’s relationships, project integrator and capital formation capabilities and Cybernetic Intelligence’s expertise in sovereign AI, we have the opportunity to pursue projects where the need for advanced nuclear power is tied to identifiable demand.”

“The opportunity in advanced nuclear now turns on execution. We must convert strong technology into financeable, buildable projects. That requires the right technology, customers, capital, regulatory strategy and development expertise in one place,” said Michael W. Hewitt, Chief Executive Officer of IP3 Corporation. “NANO Nuclear brings deep expertise on advanced reactor technology and fuel capabilities to the table. Together we look forward to exploring projects across the infrastructure markets where energy security and resilience matter most.”

“Compute sovereignty ultimately depends on energy sovereignty. As governments and critical industries deploy increasingly powerful AI systems, access to secure, dedicated and resilient power will become an increasingly important part of the infrastructure equation,” said Maxim Serezhin, Chief Executive Officer of Cybernetic Intelligence. “We believe advanced nuclear can play an important role in meeting that requirement. By bringing together Cybernetic Intelligence’s AI capabilities and vertically integrated compute systems, IP3’s infrastructure development expertise and NANO Nuclear’s advanced nuclear platform, this collaboration creates a compelling foundation to explore sovereign AI applications.”

The LOI, which was formally executed last month, represents a non-binding and non-excusive framework for exploration of opportunities among the parties. Any future projects remain subject to further diligence, applicable regulatory and governmental approvals, financing and the negotiation and execution of applicable definitive agreements.

About IP3 Corporation

IP3 is a U.S.-based nuclear infrastructure integrator, operating through a buy-side integrator model, focused on the development and operation of peaceful and secure civilian nuclear power projects domestically and globally, with wholly owned subsidiaries IP3 Security Co. and Allied Nuclear Partners Inc. that extend IP3’s reach across security and nuclear partnership domains.

About Cybernetic Intelligence LLC

Cybernetic Intelligence develops distributed, autonomous, explainable, and auditable AI systems designed for mission critical industrial, military, and intelligence operations. Our software bridges soft computing, control theory, advanced sensing, and mission-ready engineering to enable real-time environmental response and autonomous reasoning optimization. www.cyberintel.tech

About NANO Nuclear Energy, Inc.

NANO Nuclear Energy Inc. (NASDAQ: NNE) is a North American advanced technology-driven nuclear energy company seeking to become a commercially focused, diversified, and vertically integrated company across five business lines: (i) cutting edge portable and other microreactor technologies, (ii) nuclear fuel supply chain, (iii) nuclear fuel transportation, (iv) nuclear applications for space and (v) nuclear industry consulting services.

Led by a world-class nuclear engineering team, NANO Nuclear’s reactor products in development include the proprietary KRONOS MMR™ Energy System, a stationary high-temperature gas-cooled reactor that is in construction permit pre-application engagement U.S. Nuclear Regulatory Commission (NRC) in collaboration with University of Illinois Urbana-Champaign, the ZEUS™ system, a portable solid core battery reactor, and the space focused, portable LOKI MMR™ system, each representing advanced developments in clean energy solutions that are portable, on-demand capable, advanced nuclear microreactors.

Advanced Fuel Transportation Inc. (AFT), a NANO Nuclear subsidiary, bolstered by the May 2026 acquisition of Secured Transportation Services (STS), is led by former executives from the largest transportation company in the world and provides nuclear engineering and materials transport services in the U.S. and globally. Through NANO Nuclear, AFT is the exclusive licensee of a patented high-capacity HALEU fuel transportation basket developed by three major U.S. national nuclear laboratories and funded by the Department of Energy.

HALEU Energy Fuel Inc. (HEF), a NANO Nuclear subsidiary, is focusing on the future development of a domestic source for a High-Assay, Low-Enriched Uranium (HALEU) fuel fabrication pipeline for NANO Nuclear’s own microreactors as well as the broader advanced nuclear reactor industry.

NANO Nuclear Space Inc. (NNS), a NANO Nuclear subsidiary, is exploring the potential commercial applications of NANO Nuclear’s developing micronuclear reactor technology in space. NNS is focusing on applications such as the LOKI MMR™ system and other power systems for extraterrestrial projects and human sustaining environments, and potentially propulsion technology for long haul space missions. NNS’ initial focus will be on cis-lunar applications, referring to uses in the space region extending from Earth to the area surrounding the Moon’s surface.

For more corporate information please visit: https://NanoNuclearEnergy.com/

For further NANO Nuclear information, please contact:

Email: IR@NANONuclearEnergy.com
Business Tel: (212) 634-9206

PLEASE FOLLOW OUR SOCIAL MEDIA PAGES HERE:

NANO Nuclear Energy LINKEDIN
NANO Nuclear Energy YOUTUBE
NANO Nuclear Energy X PLATFORM

Cautionary Note Regarding Forward Looking Statements

This news release and statements of NANO Nuclear’s management and collaborators in connection with this news release contain or may contain “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements related to future events, which may impact our expected future business and financial performance, and often contain words such as “expects”, “anticipates”, “intends”, “explore,” “plans”, “aim,” “goal,” “believes”, “potential”, “future,” “will”, “should”, “could”, “would” or “may” or derivations of these words and other words of similar meaning about the future, although forward-looking statements could be denoted by other terms as well. In this press release, forward-looking statements include those relating to the anticipated potential benefits to NANO Nuclear of the LOI with IP3 and Cybernetic Intelligence described herein (which LOI is non-binding, non-exclusive and subject to risks and uncertainties and potential opportunities to be explored under such LOI). These and other forward-looking statements are based on information available to us as of the date of this news release and represent management’s current views and assumptions. Forward-looking statements are not guarantees of future performance, events or results and involve significant known and unknown risks, uncertainties and other factors, which may be beyond our control. For NANO Nuclear, particular risks and uncertainties that could cause our actual future results to differ materially from those expressed in our forward-looking statements include but are not limited to, risks associated with the preliminary, non-binding nature of the framework LOI described herein, including that definitive agreements with respect to any projects may never be entered into by the Company under the LOI, as well as the following: (i) risks related to our U.S. Department of Energy (“DOE”), U.S. Nuclear Regulatory Commission (“NRC”), Canadian Nuclear Safety Commission (“CNSC”) or related state or other U.S. or non-U.S nuclear licensing submissions, (ii) risks related the development of new or advanced technology and the acquisition of complementary technology or businesses, including difficulties with design and testing, cost overruns, regulatory delays, integration issues and the development of competitive technology, (iii) risks related to our ability to obtain key vendor, technology and customer contracts and the significant funding necessary to execute on our business plan, (iv) risks related to uncertainty regarding our ability to technologically develop and commercially deploy a competitive advanced nuclear reactor or other technology in the timelines we anticipate, if ever, (v) risks related to the impact of U.S. and non-U.S. government regulation, policies and licensing requirements, including by the DOE, and the NRC, including those associated with the recently enacted ADVANCE Act and the May 23, 2025 Executive Orders seeking to streamline nuclear regulation, and (vi) similar risks and uncertainties associated with the operating a developing business a highly regulated, competitive and rapidly evolving industry, including that our plans may change and we may use our cash on hand faster or in different ways than anticipated as our business requires. Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this news release. These factors may not constitute all factors that could cause actual results to differ from those discussed in any forward-looking statement, and NANO Nuclear therefore encourages investors to review other factors that may affect future results in its filings with the SEC, which are available for review at www.sec.gov and at https://ir.nanonuclearenergy.com/financial-information/sec-filings. Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by law.

Attachment

Grand Opening on September 28th Marks 13th Location in Austin Metro

Black Rock Coffee Bar

Opening September 28th in Leander
Opening September 28th in Leander

Black Rock Coffee Bar

New Leander, TX Location Coming on September 28th
New Leander, TX Location Coming on September 28th

Scottsdale, AZ, Sept. 25, 2026 (GLOBE NEWSWIRE) — Black Rock Coffee Bar, the Oregon-born boutique coffee chain celebrated for its specialty coffees, teas, smoothies, and signature Fuel® energy drinks, is growing its footprint in the Austin area with the opening of a new store in Leander. 

The store, located at 1060 Hero Way bldg 1 suite 110, will officially open its doors on Monday, September 28th. This opening marks Black Rock’s thirteenth Austin area location and reinforces the brand’s steady expansion across the region. Guests can enjoy the following specials during opening week: 

  • Monday, 9/28: Free 16oz Drinks 
  • Tuesday, 9/29: Buy One, Get One Free Drinks 
  • Wednesday, 9/30: 50% Off a Drink w/ Food Purchase 
  • Thursday, 10/1: Signature Grand Opening Sticker with purchase, while supplies last 
  • Friday, 10/2: Free T-Shirt with purchase, while supplies last 
  • Saturday, 10/3: $2 Off Any Size Drink 

“We’re thrilled to continue growing in Austin and to bring the Black Rock experience to even more neighborhoods across the Austin Metro Area,” said Mark Davis, CEO of Black Rock Coffee Bar. “Each new store represents an opportunity to connect with the community and share our passion for great coffee and exceptional service.”  

Guests can also take advantage of the Black Rock Rewards app, where every purchase—whether in-store, online, or through the app—earns “bolts” that can be redeemed for free beverages. Recent menu additions, like Black Rock’s protein-packed Egg Bites, are also included in the program. 

Black Rock Coffee Bar is beloved for its handcrafted beverages, including the Caramel Blondie, a sweet and creamy signature blend; the Mexican Mocha, a spicy twist with hints of vanilla, almond, and cinnamon; and the Jackhammer, a vanilla mocha with an extra double shot; as well as its in-house developed Fuel energy drink, customizable with over 20 fruit flavors.  These can be enjoyed alongside sweet and savory food items, including the recently launched Grilled Cheese and Pumpkin Blondie Cake Pop. For an extra kick of protein, guests can add Black Rock’s new Protein Cold Foam, Protein Boosted Milk or Protein Boost to their drinks. 

In addition to Black Rock menu staples, guests can enjoy limited-time offerings like the Pumpkin Spiced Latte, Pumpkin Blondie, and Pumpkin Spice Cookie Latte with Cookie Butter Cold Foam. The brand’s Fall Remix seasonal drinks are also now available, featuring the Caramel Apple Butter Shaken Espresso, Cinnamon Bun Latte, and Spellbound Berry Fuel, offering a mix of nostalgic and refreshing flavors.  

For more information, visit https://br.coffee/ and follow @blackrockcoffeebar on Facebook and Instagram, and @blackrockcoffeeofficial on TikTok for updates on new locations, promotions, and seasonal offerings. 

 

About Black Rock Coffee Bar  

Black Rock Coffee Bar is a national boutique coffee shop that is known for its premium roasted coffees, teas, smoothies and flavorful Fuel® energy drinks. Founded as a family owned and operated business in Oregon in 2008, Black Rock Coffee Bar has grown to over 200 retail locations in seven states. The Black Rock culture prides itself on not only being a positive force for the communities it serves, but also the team members that fuel their locations day in and day out. An important aspect of their team mission is to recognize those that go above and beyond by displaying the 4G’s of Black Rock – grit, growth, gratitude, and grace. For more information, visit https://br.coffee/. 

 

Attachments

CONTACT: Audrey Arbogast
Black Rock Coffee Bar
audrey.arbogast@havasred.com

C$6.0 million of forecast before-tax royalty cash flow during the first 12 months, based on established production and two planned oil well reactivations

CALGARY, Alberta, Sept. 25, 2026 (GLOBE NEWSWIRE) — Atlas Energy Corp. (“Atlas” or the “Company”) (TSXV: ATLE), a TSXV Sandbox issuer, is pleased to announce that on September 24, 2026, it completed the acquisition of a newly created gross overriding royalty (the “Royalty”) on the working interest of Caledonian Midstream Corp., a privately held Alberta oil and gas producer (“Vendor”), in producing oil and gas assets located in the Southwest Alberta Foothills (the “Royalty Lands”), for a cash purchase price of C$15.0 million (the “Transaction”), pursuant to a royalty purchase and sale agreement (the “Purchase Agreement”) and a gross overriding royalty agreement (the “Royalty Agreement”) entered into with Vendor on that date. The Transaction has been accepted by the TSX Venture Exchange (the “TSXV”) and, as described below, the TSXV has approved the Company’s exit from the TSXV Sandbox, which will be effective on September 29, 2026.

The Transaction represents the Atlas management team’s first investment since assuming leadership of the Company. It combines established production, highly attractive base-case returns and additional development potential not included in Atlas’s underwriting. The resulting cash flow is expected to fund the Company’s annual corporate cost base, adding a strong Canadian foundation to Atlas’s broader international royalty and streaming strategy.

Atlas has continued to evaluate and advance a broad range of international opportunities throughout the past year. The Company believes the current commodity environment reinforces the importance of disciplined underwriting and differentiated transaction structuring. With the Atlas platform expected to be largely supported by cash flow from the Royalty, the Company can remain selective as it pursues an initial international investment that demonstrates the scale, quality and repeatability of its long-term strategy.

Based on Atlas’s current base-case assumptions, the Royalty is forecast to generate approximately C$6.0 million of before-tax cash flow during the first 12 months following closing and achieve payout of Atlas’s initial investment in approximately three years.

Atlas’s base case is supported by existing production and the planned reactivation of two oil wells expected to return to production in December 2026. It assigns no value to the additional well reactivations and oil and sulphur-rich drilling opportunities identified across the Royalty Lands.

Under the Purchase Agreement, Caledonian has agreed to apply the proceeds of Atlas’s investment to the reactivation of the two Moose Mountain oil wells, the construction of a crude oil battery and truck terminal, and related pipeline and facility work on the Royalty Lands (the “Project”).

Transaction Highlights

  • C$15.0 million investment in a producing Southwest Alberta oil and gas royalty encompassing 39,023 net acres of Royalty Lands;
  • Approximately C$6.0 million of forecast before-tax royalty cash flow during the first 12 months following closing;
  • Expected payout of Atlas’s initial investment in approximately three years;
  • 9% Royalty until cumulative royalty payments to Atlas equal 2.0x its initial investment, or C$30.0 million, at which point the Royalty will step down according to a performance-aligned formula;
  • Underlying production of approximately 2,900 boe/d of hydrocarbons with 135 tonnes/d of sulphur, expected to increase to approximately 3,400 boe/d of hydrocarbons and 150 tonnes/d of sulphur following the reactivation of two oil wells anticipated to be onstream in December 2026;
  • Material development upside not included in Atlas’s base case, including additional identified reactivation opportunities and sulphur-rich drilling targets across the Royalty Lands;
  • Contracted sulphur revenue: Substantially all expected sulphur production through 2029 is sold under a long-term offtake agreement with a major investment-grade international energy company at contracted pricing, providing greater certainty regarding near-term royalty revenue. Atlas’s base-case forecast incorporates sulphur price assumptions consistent with that contracted pricing;
  • Experienced, well capitalised operator: A private upstream and midstream operator whose management team has operated the assets for eight years; and
  • Funded from cash on hand, leaving Atlas with approximately C$9.3 million of pro forma cash and liquidity to support operations and advance larger international transactions.

High-Quality Producing Assets with Identified Development Upside

The Royalty covers approximately 45,230 gross acres in the Southwest Alberta Foothills and is underpinned by current Vendor production of approximately 2,900 boe/d of hydrocarbons and 135 tonnes/d of sulphur.

The Royalty Lands are operated by Vendor, a private upstream and midstream oil and gas company with eight years of operating history on the assets. Vendor is in a net cash position today and is led by a highly experienced management team with extensive technical and operating knowledge of the properties.

Current hydrocarbon production consists of approximately 67% natural gas and 33% liquids, alongside significant sulphur production.

Atlas’s base case incorporates the reactivation of two existing oil wells that are expected to return to production in December 2026. Following these reactivations, underlying hydrocarbon production is forecast to increase to approximately 3,400 boe/d with sulphur production increasing to approximately 150 tonnes/d.

Beyond the base case, the Royalty Lands contain additional identified well reactivation opportunities and prospective drilling targets, including opportunities targeting oil and sulphur-rich production.

Atlas has assigned no value to these additional reactivation or drilling opportunities in its base case economics.

Vendor will be responsible for 100% of operating and development expenditures associated with the assets, and Atlas will have no obligation to contribute additional capital to maintain its Royalty interest.

Attractive Sulphur Economics and Contracted Pricing

A distinguishing feature of the assets is their exposure to sulphur production.

Substantially all expected sulphur production is subject to contracted offtake pricing from 2027 through 2029 under an agreement with a major investment-grade international energy company. The contracted pricing for produced volumes over the applicable period provides greater certainty regarding the Royalty’s near-term cash flows.

Atlas’s forecast royalty revenue and payout period incorporate sulphur price assumptions consistent with the contracted pricing through 2029, averaging approximately US$315/MT over 2027 to 2029. The specific terms of the offtake agreement are confidential. Following expiry of the agreement, Atlas’s base case assumes sulphur pricing of US$150/MT for 2030 and US$75/MT thereafter.

Performance-Aligned Royalty Structure

Under the terms of the Royalty Agreement, Atlas receives a 9% Royalty on Vendor’s working interest share of all petroleum substances (including natural gas, crude oil, natural gas liquids and sulphur) produced and sold from the Royalty Lands, calculated by reference to the realized market price and free of all costs and deductions other than Vendor’s third-party transportation costs attributable to the Royalty share.

The Transaction also incorporates a performance incentive designed to align Atlas and Vendor around accelerated investment in and development of the Royalty Lands. The 9% Royalty will remain in effect until cumulative royalty payments received by Atlas equal C$30 million, representing 2.0x Atlas’s initial investment, at which point the Royalty will step down to a 4% residual Royalty thereafter. If the 2.0x threshold is achieved within five years of closing, the residual Royalty will instead step down to 2%.

The five-year incentive threshold is not assumed in Atlas’s base-case economics.

Management Commentary

“We are proud to have completed Atlas Energy’s first investment,” said Mark Hodgson, President and Chief Executive Officer of Atlas. “It is a high-quality royalty over established production, operated by a team with deep knowledge of the assets. The investment was made at an entry multiple that delivers highly attractive base-case returns from a long-duration royalty interest, without relying on the broader development potential we see across the Royalty Lands. It reflects the discipline we intend to bring to every Atlas investment: acquire long duration commodity exposure on attractive terms while retaining meaningful exposure to future development upside.”

“We worked with Caledonian to create a royalty that meets its capital requirements aligns both parties around accelerated development of the assets. The additional opportunities beyond the two planned oil well reactivations are excluded from our base-case economics. This ability to create tailored and aligned capital solutions will be central to how Atlas differentiates itself.”

“The transaction also strengthens Atlas financially. The royalty is expected to fund our corporate cost base, allowing the platform to largely carry itself while we direct future investment capital toward larger opportunities. That strategic benefit makes an already attractive investment particularly valuable to Atlas at this stage of our development.”

“With this foundation in place, our team’s focus narrows to the selection and execution of Atlas’s first international royalty or streaming transaction from a robust opportunity set. Over the past year, we have built the technical, commercial and cross-border capabilities needed to pursue those investments and developed an active pipeline of opportunities. We intend to remain disciplined: our first international investment should deliver an attractive risk-adjusted return and demonstrate a repeatable model for building a global oil and gas royalty and streaming business.”

Base-Case Assumptions

Atlas’s base-case economic forecast incorporates Edmonton Light and AECO forecast pricing through 2029, with long-term pricing thereafter of US$60.69/bbl and C$2.50/GJ, respectively.

  2027 2028 2029 Long Term
Edmonton Light (US$/bbl)1 US$75.71 US$66.09 US$62.42 US$60.69
AECO (C$/GJ)2 C$2.11 C$2.61 C$2.64 C$2.50
Sulphur (US$/MT) Contracted Contracted Contracted US$150/75
USD/CAD 0.72 0.72 0.72 0.72

The forecast before-tax royalty revenue and payout period set out in this news release are based on Atlas’s internal base-case forecast, which reflects existing production from the Royalty Lands, Atlas’s forecast of the reactivation of two Moose Mountain oil wells in December 2026, and the commodity price, sulphur price and exchange rate assumptions set out above, and which assigns no value to additional reactivation or drilling opportunities. The production forecasts underlying the base case were prepared internally by Atlas; they are not estimates of reserves or future net revenue prepared in accordance with National Instrument 51-101 – Standards of Disclosure for Oil and Gas Activities (“NI 51-101”) and have not been prepared or audited by an independent qualified reserves evaluator.

Transaction Completion and TSXV Sandbox Exit

The C$15.0 million investment was funded entirely from Atlas’s existing cash resources. No securities of Atlas were issued in connection with the Transaction.

The Transaction was completed on September 24, 2026 following receipt of the conditional acceptance of the TSXV. The TSXV’s final acceptance of the Transaction is expected to be evidenced by a bulletin of the TSXV to be issued today. The Transaction is an arm’s length transaction, no finder’s fee was payable in connection with it, and it did not result in the creation of a new Control Person (as defined in the policies of the TSXV) or a change of control of the Company.

Since June 24, 2025, the Company has been listed on the TSXV pursuant to the TSXV Sandbox, subject to exit conditions that required, among other things, that the Company deploy at least 50% of its available funds following completion of its June 2025 private placement to fund qualifying investments satisfactory to the TSXV. On September 24, 2026, the TSXV determined that, upon completion of the Transaction, the Company had satisfied the exit conditions and approved the Company’s exit from the TSXV Sandbox. The TSXV’s bulletin evidencing that approval is expected to be issued today, and the Company’s exit from the TSXV Sandbox will be effective at the opening of trading on September 29, 2026 (the “Exit Date”). Until the Exit Date, the Company remains listed pursuant to the TSXV Sandbox and subject to the TSXV Sandbox listing conditions. From the Exit Date, the Company will no longer be a TSXV Sandbox issuer and its common shares will continue to trade on the TSXV as a Tier 2 issuer. As a result of the exit, the release schedule under the Company’s escrow agreement will apply retroactively from June 24, 2025, and 110,886,676 common shares and 110,775,811 warrants held by the Company’s principals will be released from escrow on or about the Exit Date. Investors are advised to read the Company’s news releases dated June 16, 2025 and June 22, 2026 for information regarding the waivers granted and the conditions imposed in connection with the Company’s TSXV Sandbox listing.

Stikeman Elliott LLP acted as legal counsel to Atlas in connection with the Transaction.

About Atlas Energy Corp.

Atlas Energy Corp. is an upstream royalty and streaming company focused on the acquisition and management of a diversified portfolio of oil and gas royalty and streaming interests across key global markets. Atlas’s common shares are listed on the TSXV under the symbol “ATLE”.

For Further Information

Mark Hodgson, President & Chief Executive Officer | Travis Doupe, Chief Financial Officer | Atlas Energy Corp., Suite 3200 Dome Tower, 333 7th Avenue SW, Calgary, Alberta T2P 2Z1 | +1 (403) 680-9626 |   info@atlas-corp.ca | www.atlas-corp.ca 

Forward-Looking Information

This news release contains forward-looking statements and forward-looking information within the meaning of applicable Canadian securities laws (collectively, “forward-looking statements”). The use of any of the words “expect”, “anticipate”, “continue”, “estimate”, “forecast”, “objective”, “ongoing”, “may”, “will”, “project”, “should”, “believe”, “plans”, “intends”, “target” and similar expressions (including negatives and variations thereof) are intended to identify forward-looking statements. More particularly and without limitation, this news release contains forward-looking statements concerning: the anticipated benefits of the Transaction and the terms of the Royalty, the Purchase Agreement and the Royalty Agreement; the forecast royalty revenue to be received by Atlas from the Royalty, including during the first 12 months following closing; the forecast payout period of Atlas’s investment and the anticipated timing of achieving the 2.0x payout threshold; current and forecast production from the Royalty Lands, including the timing and results of the planned reactivation of two wells and the expected increase in hydrocarbon and sulphur production; the additional well reactivation and drilling opportunities identified on the Royalty Lands and Vendor’s development plans, including the Project; contracted sulphur pricing and volumes under Vendor’s sulphur offtake arrangements; the commodity price, sulphur price and foreign exchange assumptions underlying Atlas’s base case; Atlas’s cash position following completion of the Transaction and the expectation that royalty revenue will fund the Company’s corporate cost base; the Company’s views regarding the commodity environment; Atlas’s business strategy, including its intention to pursue and complete an initial international royalty or streaming investment and its pipeline of such opportunities; the issuance by the TSXV of its bulletins evidencing final acceptance of the Transaction and approval of the Company’s exit from the TSXV Sandbox; and the timing and consequences of the Company’s exit from the TSXV Sandbox, including the release of escrowed securities.

The forward-looking statements are based on certain key expectations and assumptions made by the Company, including expectations and assumptions concerning: Vendor’s performance of its obligations under the Purchase Agreement and the Royalty Agreement, including the application of the proceeds of Atlas’s investment to the Project; the accuracy and completeness of the production, cost, contractual and other information provided by Vendor; the timing and results of the planned well reactivations, including their return to production in December 2026; production and decline rates; future commodity prices, including crude oil, natural gas and sulphur prices, and the performance by Vendor’s sulphur offtake counterparty of its obligations; exchange rates, interest rates and inflation rates; Crown and other royalty rates and applicable tax laws; the availability of international royalty and streaming opportunities on commercially reasonable terms and of financing for future transactions; the issuance of the TSXV’s bulletins and the effectiveness of the Company’s exit from the TSXV Sandbox on the anticipated timing; and government regulations, laws and tariffs.

Although the Company believes that the expectations and assumptions on which such forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. By their nature, forward-looking statements are subject to various risks and uncertainties which could cause actual results and expectations to differ materially from the anticipated results or expectations expressed. These risks and uncertainties include, but are not limited to: the failure to realize some or all of the anticipated benefits of the Transaction, including forecast royalty revenue and payout; production from the Royalty Lands being lower than forecast, including as a result of delays in or the failure of the planned well reactivations, higher than expected decline rates, operational difficulties, shut-ins, facility outages or the sour nature of the production; Vendor’s ability to fund and carry out the Project and its other development plans and to perform its obligations under the Purchase Agreement, the Royalty Agreement and its sulphur offtake arrangements, and counterparty credit risk; Atlas’s reliance on Vendor as operator of the Royalty Lands and the absence of any right of Atlas to control operations or development on the Royalty Lands; fluctuations in commodity prices, including sulphur prices, which have historically been volatile, and determinations and curtailments made by OPEC+ regarding production levels; changes in industry regulations, royalty regimes, environmental regulation and the political landscape both domestically and abroad; fluctuations in foreign exchange and interest rates; stock market volatility; the imposition or expansion of tariffs or other restrictive trade measures by domestic or foreign governments and their effect on demand for and the market price of oil, natural gas and sulphur; the availability of investment opportunities meeting the management team’s investment criteria and of financing for future transactions on acceptable terms; the retention of key management and employees; any delay in the issuance of the TSXV’s bulletins or in the effectiveness of the Company’s exit from the TSXV Sandbox; and obtaining required approvals of regulatory authorities. The foregoing list is not exhaustive. Please refer to the Company’s management’s discussion and analysis for the three and six months ended June 30, 2026 and the Company’s annual information form for the year ended December 31, 2025 dated April 6, 2026 for discussion of additional risk factors relating to Atlas, which can be accessed on its SEDAR+ profile at www.sedarplus.ca.

Readers are cautioned not to place undue reliance on this forward-looking information, which is given as of the date hereof, and to not use such forward-looking information for anything other than its intended purpose. The Company undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

Financial Outlook. This news release contains future-oriented financial information and financial outlook information (collectively, “FOFI”) about Atlas’s forecast royalty revenue and payout period from the Royalty and its pro forma cash position, which are subject to the same assumptions, risk factors, limitations and qualifications as set forth above and under “Base-Case Assumptions”. The FOFI was approved by Atlas’s management as of the date of this news release and is included to provide readers with an understanding of Atlas’s expectations regarding the economic returns from the Royalty and its financial position following the Transaction. Readers are cautioned that the FOFI may not be appropriate for other purposes and that actual results may vary materially from the FOFI. The Company disclaims any intention or obligation to update or revise any FOFI, except as required by applicable securities laws.

Oil and Gas Advisories

Barrels of Oil Equivalent. Per barrel of oil equivalent (“boe”) amounts in this news release have been calculated using a conversion rate of six thousand cubic feet of natural gas to one barrel of oil (6 Mcf:1 bbl). Boes may be misleading, particularly if used in isolation. A boe conversion ratio of 6 Mcf:1 bbl is based on an energy equivalency conversion method primarily applicable at the burner tip and does not represent a value equivalency at the wellhead. As the value ratio between natural gas and crude oil based on current prices is significantly different from the energy equivalency of 6:1, utilizing a conversion on a 6:1 basis may be misleading as an indication of value. Sulphur volumes are expressed in tonnes per day and are not included in boe figures.

Product Types. References in this news release to “natural gas” mean conventional natural gas; references to “natural gas liquids” or “NGLs” include ethane, propane, butane and pentanes plus; references to “liquids” include crude oil, condensate and NGLs; and references to “oil” or “crude oil” mean light crude oil and medium crude oil combined, each as defined in NI 51-101.

Production Information. Production information for the Royalty Lands in this news release is based on information provided by Vendor as at September, 2026 and refers to gross production from Vendor’s working interest in the Royalty Lands, before deduction of royalties, and not to the share of production attributable to the Royalty. Production from the Royalty Lands as at August, 2026 consisted of approximately 11.7 MMcf/d of conventional natural gas, 230 bbl/d of light and medium crude oil and 725 bbl/d of natural gas liquids, together with approximately 135 tonnes/d of sulphur. Atlas has not independently verified this information.

Oil and Gas Metrics. This news release contains certain oil and gas metrics, including payout, which do not have standardized meanings or standard methods of calculation and therefore may not be comparable to similar measures used by other companies and should not be used to make comparisons. Such metrics have been included to provide readers with additional measures to evaluate the Royalty; however, they are not reliable indicators of future performance and should not be unduly relied upon. References in this news release to additional well reactivation opportunities and drilling targets on the Royalty Lands are to opportunities identified by Vendor and Atlas based on existing well data and internal technical analysis; no reserves or value have been attributed to them, and there is no certainty that any such wells will be reactivated or drilled or that, if they are, they will result in additional production.

Third-Party Information

Certain information in this news release relating to Vendor, the Royalty Lands, historical and current production and development opportunities has been provided by Vendor or derived from publicly available sources. Although Atlas believes such information to be reliable, Atlas has not independently verified it and does not make any representation or warranty as to its accuracy or completeness. Vendor is not a reporting issuer and does not itself file reports with securities regulatory authorities.

TSXV Sandbox Listing

Investors are advised that the Company is currently listed on the TSXV as a TSXV Sandbox Listing as the Company did not meet all of the TSXV’s listing requirements at the time of listing. As described above, the TSXV has approved the Company’s exit from the TSXV Sandbox, which will be effective at the opening of trading on October 6, 2026. Investors are advised to review the Company’s news releases dated June 16, 2025 and June 22, 2026 to review all waivers granted in connection with the Company’s listing, details on the listing conditions imposed on the Company, the exit conditions the Company must meet in order to exit the TSXV Sandbox, and any consequences if the Company does not meet these exit conditions. For details on TSXV Sandbox Listings, please visit https://www.tsx.com/en/listings/tsx-and-tsxv-issuer-resources/tsx-venture-exchange-issuer-resources/tsxv-sandbox. 

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

All dollar figures in this news release are presented in Canadian dollars unless otherwise noted. “US$” refers to United States dollars.


1 Based on forward prices as of September 17, 2026
2 Based on Scotia strip price forecasts as of September 16, 2026

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.